Drug Usage Clinical Trial
Official title:
Effect-site Concentration of Remifentanil for Preventing Propofol Injection Pain in Elderly Patients: A Comparison With Adult Patients
Elderly patients show different pharmacokinetic and pharmacodynamic variables and usually need smaller doses of anesthetic drugs than younger patients. The purpose of this study was to investigate the optimal effect-site concentration of remifentanil for preventing injection pain during propofol induction in elderly patients by the Dixon's up-and-down method.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06020391 -
Cooperation for Better Treatment of Polypharmacy in the Community
|
N/A | |
Completed |
NCT02490345 -
Gabapentin as Adjunctive Treatment for Postoperative Pain Control
|
Phase 1 | |
Completed |
NCT01931683 -
Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)
|
Phase 4 | |
Withdrawn |
NCT03938077 -
A Community-University Approach to Preventing HIV
|
N/A | |
Completed |
NCT02973724 -
EC95 of Remifentanil for Preventing Cough
|
N/A | |
Completed |
NCT01152970 -
F.Y.I.: Flint Youth Injury Study
|
N/A | |
Completed |
NCT01489683 -
Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine
|
N/A | |
Completed |
NCT03368456 -
Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention
|
N/A | |
Completed |
NCT02379455 -
Cooperation for Improved Pharmacotherapy in Home-dwelling Elderly People Receiving Polypharmacy - The COOP Study
|
N/A | |
Completed |
NCT01852539 -
Dexmedetomidine for Laryngeal Mask Airway Insertion
|
Phase 4 | |
Completed |
NCT01963130 -
Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study
|
N/A | |
Recruiting |
NCT01496105 -
Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion
|
Phase 4 | |
Completed |
NCT02334046 -
Remifentanil for Smooth Emergence in Elderly Patients
|
Phase 4 | |
Completed |
NCT00876941 -
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
|
Phase 3 |